Tag Archives: from

After $600M sales hit from pandemic, Merck’s open to ‘all forms’ of M&A deals, incoming CEO says

With Merck’s sales dragging from the pandemic and the company becoming increasingly reliant on immuno-oncology superstar Keytruda, the pharma giant’s executive team unveiled a willingness to flex its M&A muscle. “We are open to any opportunity to add a meaningful asset,” president and soon-to-be CEO Rob Davis said on a Thursday call with investors. “We… Read More »

Virtual Health Tech Enables the Continuum of Health from Hospital to Home

In the COVID-19 pandemic, as peoples’ daily lives shifted closer and closer to home, and for some weeks and months home-all-the-time, health care, too, moved beyond brick-and-mortar hospitals and doctors’ offices. The public health crisis accelerated “what’s next” for health care delivery, detailed in A New Era of Virtual Health, a report published by TripleTree. TripleTree… Read More »

More than half Canada’s AstraZeneca vaccine came from U.S. plant accused by FDA of quality-control problems

Breadcrumb Trail Links World Reopening Canada PostPandemic News National More Reopening Canada Health and Wellness Health Canada Controversy first erupted in March when it was revealed that cross-contamination at the Baltimore plant had ruined 15 million doses of the J&J product Author of the article: Tom Blackwell Publishing date: Apr 23, 2021  •  1 hour ago… Read More »

New Research from the CWMH: No Increase in Major Malformations in Children Prenatally Exposed to Aripiprazole

Despite the increasing use of the newer atypical or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including psychotic disorders, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little data on the reproductive safety of these newer atypical agents. In response to this deficit, the National Pregnancy Registry for… Read More »